Ninety-eight now sick from romaine lettuce-linked E. coli: CDC

(Reuters) - Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said on Friday, bringing the number of people affected to 98 across 22 U.S. states.

Hong Kong scrambles for talent in battle for Nasdaq's biotech crown

HONG KONG (Reuters) - When Hong Kong unveiled plans last year to encourage biotech companies to list in the city by loosening listing rules, the financial industry and investors cheered.

Zimbabwe says will issue cannabis licences to growers

HARARE (Reuters) - Zimbabweans can now apply for licences to grow cannabis for medical and research purposes, the government has said in a legal notice, making the southern African nation the second country in Africa to legalize cultivation of the plant.

Allergan migraine drug succeeds in second late-stage trial

NEW YORK (Reuters) - Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results from the previous trial.

Talk therapy may help soldiers combat insomnia

(Reuters Health) - Talk therapy for insomnia is effective at reducing insomnia, as well as mental fatigue, among military personnel, according to a new study.

Global study finds 44 genetic risk factors for major depression

LONDON (Reuters) - International scientists have identified 44 genetic variants that can increase the risk of developing major depression and found that all humans carry at least some of them.

China to cut import value-added tax on cancer drugs from May 1

BEIJING (Reuters) - China will cut the import value-added tax on cancer drugs to 3 percent from May 1, the Finance Ministry said on Friday.

Eating better tied to lower risk of liver disease

(Reuters Health) - People who make an effort to improve their diet may be more likely to have less fat in their livers and a lower risk of liver disease than individuals who stick to unhealthy eating habits, a U.S. study suggests.

Gilead's three-drug HIV regimen wins European panel approval

(Reuters) - Gilead Sciences Inc said on Friday its three-drug regimen to treat HIV infection was recommended for approval by a panel of the European Medicines Agency, paving the way for the biotech company to capture more sales in the multibillion-dollar market.

Fewer dementia patients die after surgery when nurses more educated

(Reuters Health) - Patients with Alzheimer's disease and dementia may be less likely to die after surgery when they're treated at hospitals that employ a larger proportion of nurses with at least a college degree, a U.S. study suggests.

Related Videos

Cheech and Chong's careers highlighted at Grammy Museum

In time for 4/20, a new exhibition is put on at the Grammy Museum in Downtown Los Angeles celebrating the cult stoner film "Up in Smoke". Rough Cut - no reporter narration

UK firm turns discarded gum into shoes, coffee cups, and combs

Chewing gum is a blight on city streets and takes a heavy toll on the environment, say its critics. But one woman in Britain is performing modern-day alchemy on it - Gumdrop founder Anna Bullus - as Amber Austin-Wright found out.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here